Peptide

Kisspeptin-10

Also known as

Kisspeptin · Kp-10 · KP-10 · Kisspeptin 10 · Kisspeptin-10 amide · Metastin (45-54) · Metastin fragment (Kp-10) · KISS-1 (112-121) · Human metastin 45-54 · YNWNSFGLRF-NH2

Community talk. May contain inaccuracies. Not medical advice. Not a protocol. Not for human or animal use.

What it is

Reproductive-signaling peptide	Kisspeptin-10 activates an upstream brain signal involved in LH/FSH release. People discuss it for desire, orgasm difficulties and testosterone support.
Different forms and signals	Kisspeptin-54 trials, hCG and TRT are different. A libido change with Kisspeptin-10 does not establish restored fertility or an hCG replacement.

Notes

Kisspeptin-10 is a short reproductive-signaling peptide discussed for sexual desire, orgasm difficulties and testosterone support. Some users describe renewed arousal or easier orgasm; others notice nothing or develop troubling symptoms. Its upstream hormone signal does not establish that it restores fertility, reverses PSSD or replaces hCG.

An upstream reproductive signal. The ten-amino-acid fragment activates the KISS1R receptor. That can prompt the brain's GnRH signal, followed by pituitary LH and FSH hormones communicating with the testes or ovaries. It supplies a signal rather than testosterone itself; the rest of the pathway must respond. FDA October 29, 2024 PCAC slides: Kisspeptin-10 evaluation (Official context · Accessed 2026-09-30)

Kisspeptin-10 and Kisspeptin-54 are different forms. The low-desire trial used Kisspeptin-54 through an IV infusion. That differs from Kisspeptin-10 injections and nasal products; its results cannot validate their amounts or schedules. Mills et al.: Sexual processing and penile tumescence in men with HSDD (Official context · Accessed 2026-09-30)

hCG comparisons are about different signals. hCG acts at the testes; gonadorelin supplies the downstream GnRH signal; enclomiphene and clomiphene alter hormone feedback. People on testosterone replacement (TRT) discuss switching or combining them with Kisspeptin-10. A libido change does not establish restored sperm production or testicular function.

Source context — FDA October 29, 2024 PCAC slides: Kisspeptin-10 evaluation: Dated 2024 assessment, not a current-law determination or a user experience. Nonclinical safety concerns do not establish human cardiovascular outcomes. PK reported in slides summarizes Jayasena's human IV work, not community SC clearance.

Source context — Mills et al.: Sexual processing and penile tumescence in men with HSDD: Abstract only; not Kisspeptin-10, PSSD, chronic treatment or home administration. No safety assurance generalized from short trial visits.

What people notice

Sexual function	One PSSD author reported easier orgasm and smaller changes in sensation, erections and desire, with no improvement in brain fog or motivation. A nasal user described renewed arousal.
Mixed or no response	Other accounts include no change after two months, happier mood without a testosterone increase, and libido improvement without restored testicular size.

Notes

Easier orgasm can matter more than stronger desire. One r/PSSD author described easier orgasm as the clearest benefit, with smaller changes in sensation, erections and desire. They explicitly remained symptomatic and reported no improvement in brain fog or motivation. After 11 Years of PSSD, Kisspeptin-10 is the first thing that helps me (Personal report · Accessed 2026-09-30)

Some describe the return of a sexual spark. A nasal-use account described renewed mental arousal and morning erections after stopping TRT. Hormone changes and natural fluctuations complicate attribution. This is a person's experience, not proof of reversing post-finasteride symptoms. Update: My Personal Kisspeptin-10 Experience (>1 Month Update) (Personal report · Accessed 2026-09-30)

No benefit after two months also appears. One r/PSSD poster initially claimed at least 200 mcg daily with no change, then admitted taking half the amount they thought. They had not checked hormones during use. The nonresponse remains useful; the stated exposure is uncertain. Kisspeptin 10 been using everyday for 60 days (Community discussion · Accessed 2026-09-30)

Feeling better and raising testosterone are separate outcomes. An r/Peptides contributor reported feeling happier and more reflective without a testosterone increase at 100 mcg daily. Other peptides were involved. A later hormone result followed both a schedule change and added gonadotropin treatment (HMG), so it cannot isolate Kisspeptin-10. Experience with Kisspeptin 10? (Community discussion · Accessed 2026-09-30)

Libido and testicular size can diverge. The ExcelMale TRT user described improved comfort and libido but no restored size. They acknowledged other hormones could explain libido. That is a narrower outcome than an hCG-replacement claim. Kisspeptin-10: SeaDweller's TRT-adjunct account (Personal report · Accessed 2026-09-30)

Source context — After 11 Years of PSSD, Kisspeptin-10 is the first thing that helps me: One person; previous hCG/TRT and other interventions; no verified product or controls. Body and its bot duplicate are one report. Legal/safety assurances in comments are not adopted.

Source context — Update: My Personal Kisspeptin-10 Experience (>1 Month Update): One unverified account; prior TRT and later additional hormones. Labeled spray amounts do not measure absorption. Retrospective baseline percentages are not objective efficacy estimates. Urinary/testicular symptoms remained in original body.

Source context — Kisspeptin 10 been using everyday for 60 days: Multiple users with unknown products/co-use; dosing correction prevents precise exposure. Twice-weekly user reports syringe marks without concentration, so no mcg inferred. Reported receptor-overwhelm explanation is opinion.

Source context — Experience with Kisspeptin 10?: Deleted account identity; route of the experience comment not explicitly given; stacks prevent attribution. A reply of 0.1 mL twice weekly has no concentration and is not converted to mcg. Four-minute statement repeats formal PK.

Source context — Kisspeptin-10: SeaDweller's TRT-adjunct account: One TRT user with other hormone context; concentrations/route not explicitly stated in the numbered mcg posts. Lab numbers lack complete units/reference ranges. Thread has commercial sponsors; not a controlled treatment comparison.

Doses people talk about

Daily injections	One diary reports 100–150 mcg once daily SC. A different injection post gives 100 mcg total daily split into two injections, with route not explicitly established there.
Intermittent reports	One user reported 100 mcg Monday/Wednesday/Friday, later 150 mcg. Older SC discussion includes 100 mcg two or three times weekly and twice-weekly maintenance.
Other SC charts	50–100 mcg, 100–200 mcg per injection and 125 mcg at bedtime circulate. Higher 200–400 mcg reports and 300–1,000 mcg commercial tiers mix goals and sometimes peptide forms; no best amount is established.
Nasal account	One author reported 66.6 mcg intranasally once daily, later one spray. Labeled spray amounts do not measure absorption or equal injection amounts.

Notes

SC: 100–150 mcg once daily in one diary. One PSSD author's linked reports describe 100–150 mcg daily SC. Another injection post gives 100 mcg total daily split into two injections, not 100 mcg each. After 11 Years of PSSD, Kisspeptin-10 is the first thing that helps me (Personal report · Accessed 2026-09-30) · Quick update regarding my Kisspeptin-10 journey (Personal report · Accessed 2026-09-30) · Kisspeptin 10 first time using (Community discussion · Accessed 2026-09-30)

OP: 100 mcg daily split into two injections; OP five-day/earlier ten-day update with Fadogia co-use; Ok_Fee7426 libido/erection response within days while on TRT; later frequency advice is not validation. Kisspeptin 10 first time using (Community discussion · Accessed 2026-09-30)

Intermittent injections: 100–150 mcg, three times weekly. An ExcelMale user reported 100 mcg Monday/Wednesday/Friday, later 150 mcg. Original SC discussion also includes 100 mcg two or three times weekly, and twice-weekly maintenance. These differ from daily totals. Kisspeptin-10: SeaDweller's TRT-adjunct account (Personal report · Accessed 2026-09-30)

Other SC amounts circulate, without a settled best dose. The original community/chart record includes 50–100 mcg lower amounts, 100–200 mcg per injection, and 125 mcg at bedtime. Higher reports include 200–400 mcg and a broad 100–1,000 mcg span; commercial charts call 300–500 mcg mid-range and 600–1,000 mcg high or IVF-style. Those chart labels mix forms and goals; they do not establish effectiveness.

Nasal amounts cannot be equated with injections. One author reported 66.6 mcg intranasally once daily, later reducing to one spray. The labeled spray amount is not the absorbed amount. These claims do not establish equivalence to SC or IV exposure. Update: My Personal Kisspeptin-10 Experience (>1 Month Update) (Personal report · Accessed 2026-09-30)

Source context — Quick update regarding my Kisspeptin-10 journey: Follow-up by the same author as help, not an independent positive/adverse case. Estradiol units and clinical interpretation unverified; improvement followed more than one treatment change. No AI regimen copied.

Source context — Kisspeptin 10 first time using: Do not assume 100 mcg per injection or invent an explicitly stated SC route for the OP. Separate users; TRT/Fadogia and baseline disease confound outcomes. Promises of inevitable testosterone/size improvement rejected.

Half-life, onset & duration

Felt onset	Injection accounts describe days to about a week; one nasal account noticed more in week two. The saved record also includes two-to-four-week reports.
Felt duration	No reliable single-dose window is known. One person worsened during a five-day pause; a nasal benefit faded after days of repeated use in another account.
Half-life	3.8 minutes comes from healthy-men IV research, not home SC or nasal measurements. It does not establish the duration of desire or an ideal frequency.

Notes

Days to a week in some injection accounts. One PSSD author noticed change after about a week; another thread includes a couple-of-days response on TRT. These are individual timelines. After 11 Years of PSSD, Kisspeptin-10 is the first thing that helps me (Personal report · Accessed 2026-09-30) · Kisspeptin 10 first time using (Community discussion · Accessed 2026-09-30)

A nasal account noticed more in week two. That author reported little change in week one, then improvement in week two. The original record also contains one-to-two-week and two-to-four-week reports. Route, co-use and outcome differ; these are separate timelines. Update: My Personal Kisspeptin-10 Experience (>1 Month Update) (Personal report · Accessed 2026-09-30)

A reliable single-dose effect window is unknown. Week-by-week diaries cannot tell us the duration of one injection. One nasal commenter described intense desire for a few days followed by complete loss of effect; this is fading across repeated use, not a several-day half-life. Kisspeptin 10 been using everyday for 60 days (Community discussion · Accessed 2026-09-30)

After stopping, accounts differ. The PSSD author described worsening during a five-day pause and improvement after restarting. The nasal author later reported sustained libido one or two months after stopping Kisspeptin and progesterone, following added pregnenolone/progesterone. That mixed-treatment follow-up cannot demonstrate permanent repair. After 11 Years of PSSD, Kisspeptin-10 is the first thing that helps me (Personal report · Accessed 2026-09-30) · Update: My Personal Kisspeptin-10 Experience (>1 Month Update) (Personal report · Accessed 2026-09-30)

The four-minute clock comes from IV research. FDA summarizes a 3.8-minute plasma half-life in healthy men after IV infusion. SC absorption was not established as equivalent. This is clearance of peptide from blood, not duration of desire or downstream hormone effects. FDA October 29, 2024 PCAC slides: Kisspeptin-10 evaluation (Official context · Accessed 2026-09-30)

No measured community SC or nasal half-life here. Accounts describe administration frequency and experiences, not measured clearance. A number from a different peptide form or route cannot supply the missing home-use clock.

Cycles people discuss

Reported courses	Diaries include 40–60 days daily SC, about three months before adverse symptoms, and ongoing intermittent use. No optimum emerges.
Competing charts	30 days on/30 off, 4–6 weeks on/about four off, and vendor 8–12-week courses circulate. Fading response does not prove desensitization or a protective break schedule.

Notes

Daily courses and ongoing intermittent use coexist. Accounts include 40–60 days daily SC, three months before adverse symptoms, and ongoing twice-weekly use. These histories do not establish an optimal course length or frequency. After 11 Years of PSSD, Kisspeptin-10 is the first thing that helps me (Personal report · Accessed 2026-09-30) · Quick update regarding my Kisspeptin-10 journey (Personal report · Accessed 2026-09-30) · Kisspeptin 10 been using everyday for 60 days (Community discussion · Accessed 2026-09-30)

30 days on/off and 4–6 weeks on circulate in charts. The original record gives 30 days on/30 off; 4–6 weeks on/about four off; short 2–5-week trials; and vendor courses of 8–12 weeks, sometimes 16. Other accounts continue two or three injections weekly without a fixed break. These are competing templates, not validated cycles.

Fading prompts breaks or lower frequency in discussion. Some contributors blame frequent exposure for desensitization, meaning reduced response. Others use it daily. Original advice favors fewer injections or time off instead of escalation, but neither a four-minute half-life nor a fading libido proves the cause or a protective schedule. Kisspeptin 10 been using everyday for 60 days (Community discussion · Accessed 2026-09-30) · Experience with Kisspeptin 10? (Community discussion · Accessed 2026-09-30)

Stacks

Hormone combinations	An old example pairs SC Kisspeptin-10 100 mcg two or three times weekly with oral enclomiphene 12.5 mg daily for 8–12 weeks. TRT, hCG and gonadorelin also appear; benefits cannot be assumed.
Other peptide combinations	PT-141, oxytocin and GH-axis peptides appear in the saved stack talk without a checked combination or standardized ratio.

Notes

Stacks make dramatic laboratory changes hard to interpret. Original talk pairs SC Kisspeptin-10 100 mcg two or three times weekly with oral enclomiphene 12.5 mg daily over 8–12 weeks. hCG, gonadorelin, PT-141, oxytocin and GH-axis peptides also appear. These are discussion examples, not checked combinations or a standardized blend.

TRT + intermittent Kp-10: Discussed for libido/axis narratives on exogenous T; expected LH rise may be muted by androgen feedback. [community]

Watch for

Sleep and mood	The favorable PSSD diary later described 3–4 hours of sleep, heavy legs and emotional episodes after roughly three months. The author's estradiol explanation was unverified.
Reactions and hormones	Redness, sting, itching, swelling, headache, flushing and nausea appear in the record. Pregnancy, fertility timing and hormone-sensitive disease are consequential contexts.
Product and chronic safety	The saved FDA assessment flags limited chronic safety information and possible immune reactions from impurities or aggregation; research labeling does not assure sterility or correct fill.

Notes

An initially favorable diary later describes sleep and mood problems. After roughly three months at 100–150 mcg daily, the PSSD author described sleeping three to four hours, heavy legs and emotional episodes. They suspected estradiol and changed treatment after stopping. Self-reported hormone changes do not prove the cause or justify copying an aromatase-inhibitor response. Quick update regarding my Kisspeptin-10 journey (Personal report · Accessed 2026-09-30)

Injection reactions and hormone-sensitive situations matter. Original community cautions include redness, sting, itching and swelling, plus headache, flushing or nausea. Pregnancy, fertility timing and hormone-sensitive disease are contexts where a reproductive signal is consequential; calling it natural does not establish safety.

Product uncertainty is more than a dose question. FDA's 2024 assessment identified limited chronic safety information and possible immune reactions associated with peptide impurities or aggregation. A labeled research product does not guarantee identity, sterility or fill accuracy; short experimental tolerability cannot establish long-term safety. FDA October 29, 2024 PCAC slides: Kisspeptin-10 evaluation (Official context · Accessed 2026-09-30)

Full notes

What Kisspeptin-10 is

An upstream reproductive signal. The ten-amino-acid fragment activates the KISS1R receptor. That can prompt the brain's GnRH signal, followed by pituitary LH and FSH hormones communicating with the testes or ovaries. It supplies a signal rather than testosterone itself; the rest of the pathway must respond. Official context
Kisspeptin-10 and Kisspeptin-54 are different forms. The low-desire trial used Kisspeptin-54 through an IV infusion. That differs from Kisspeptin-10 injections and nasal products; its results cannot validate their amounts or schedules. Official context Community
hCG comparisons are about different signals. hCG acts at the testes; gonadorelin supplies the downstream GnRH signal; enclomiphene and clomiphene alter hormone feedback. People on testosterone replacement (TRT) discuss switching or combining them with Kisspeptin-10. A libido change does not establish restored sperm production or testicular function. Community

What people hope for and report

Easier orgasm can matter more than stronger desire. One r/PSSD author described easier orgasm as the clearest benefit, with smaller changes in sensation, erections and desire. They explicitly remained symptomatic and reported no improvement in brain fog or motivation. Personal report
Some describe the return of a sexual spark. A nasal-use account described renewed mental arousal and morning erections after stopping TRT. Hormone changes and natural fluctuations complicate attribution. This is a person's experience, not proof of reversing post-finasteride symptoms. Personal report
Feeling better and raising testosterone are separate outcomes. An r/Peptides contributor reported feeling happier and more reflective without a testosterone increase at 100 mcg daily. Other peptides were involved. A later hormone result followed both a schedule change and added gonadotropin treatment (HMG), so it cannot isolate Kisspeptin-10. Reddit r/Peptides

Doses people discuss

Reported amounts describe discussion and self-experiments, not an established regimen. SC means injection beneath the skin; mcg means micrograms.

SC: 100–150 mcg once daily in one diary. One PSSD author's linked reports describe 100–150 mcg daily SC. Another injection post gives 100 mcg total daily split into two injections, not 100 mcg each. Personal report Personal report Reddit r/PSSD
Intermittent injections: 100–150 mcg, three times weekly. An ExcelMale user reported 100 mcg Monday/Wednesday/Friday, later 150 mcg. Original SC discussion also includes 100 mcg two or three times weekly, and twice-weekly maintenance. These differ from daily totals. Personal report Community
Other SC amounts circulate, without a settled best dose. The original community/chart record includes 50–100 mcg lower amounts, 100–200 mcg per injection, and 125 mcg at bedtime. Higher reports include 200–400 mcg and a broad 100–1,000 mcg span; commercial charts call 300–500 mcg mid-range and 600–1,000 mcg high or IVF-style. Those chart labels mix forms and goals; they do not establish effectiveness. Community
Nasal amounts cannot be equated with injections. One author reported 66.6 mcg intranasally once daily, later reducing to one spray. The labeled spray amount is not the absorbed amount. These claims do not establish equivalence to SC or IV exposure. Personal report

Half-life in community discussion

About four minutes is a circulated research figure. An r/Peptides commenter uses this number to argue for daily dosing. Its origin is human IV pharmacokinetics, not a home injection measurement. It does not tell us how long arousal lasts or prove daily use is preferable. Reddit r/Peptides
No measured community SC or nasal half-life here. Accounts describe administration frequency and experiences, not measured clearance. A number from a different peptide form or route cannot supply the missing home-use clock. Community

When people notice a change

Days to a week in some injection accounts. One PSSD author noticed change after about a week; another thread includes a couple-of-days response on TRT. These are individual timelines. Personal report Reddit r/PSSD
A nasal account noticed more in week two. That author reported little change in week one, then improvement in week two. The original record also contains one-to-two-week and two-to-four-week reports. Route, co-use and outcome differ; these are separate timelines. Personal report Community
30–60 minutes before sex is anecdotal timing talk. The original record pairs that timing with 50–100 mcg SC as-needed claims. It is not a measured onset or the Kisspeptin-54 desire-trial design. Bedtime versus morning, and food timing, remain preferences rather than demonstrated advantages. Community Community

How long reported changes last

A reliable single-dose effect window is unknown. Week-by-week diaries cannot tell us the duration of one injection. One nasal commenter described intense desire for a few days followed by complete loss of effect; this is fading across repeated use, not a several-day half-life. Reddit r/PSSD Community
After stopping, accounts differ. The PSSD author described worsening during a five-day pause and improvement after restarting. The nasal author later reported sustained libido one or two months after stopping Kisspeptin and progesterone, following added pregnenolone/progesterone. That mixed-treatment follow-up cannot demonstrate permanent repair. Personal report Personal report

Courses and breaks people describe

Daily courses and ongoing intermittent use coexist. Accounts include 40–60 days daily SC, three months before adverse symptoms, and ongoing twice-weekly use. These histories do not establish an optimal course length or frequency. Personal report Personal report Reddit r/PSSD
30 days on/off and 4–6 weeks on circulate in charts. The original record gives 30 days on/30 off; 4–6 weeks on/about four off; short 2–5-week trials; and vendor courses of 8–12 weeks, sometimes 16. Other accounts continue two or three injections weekly without a fixed break. These are competing templates, not validated cycles. Community
Fading prompts breaks or lower frequency in discussion. Some contributors blame frequent exposure for desensitization, meaning reduced response. Others use it daily. Original advice favors fewer injections or time off instead of escalation, but neither a four-minute half-life nor a fading libido proves the cause or a protective schedule. Reddit r/PSSD Reddit r/Peptides Community

Cautions worth understanding

An initially favorable diary later describes sleep and mood problems. After roughly three months at 100–150 mcg daily, the PSSD author described sleeping three to four hours, heavy legs and emotional episodes. They suspected estradiol and changed treatment after stopping. Self-reported hormone changes do not prove the cause or justify copying an aromatase-inhibitor response. Personal report
Injection reactions and hormone-sensitive situations matter. Original community cautions include redness, sting, itching and swelling, plus headache, flushing or nausea. Pregnancy, fertility timing and hormone-sensitive disease are contexts where a reproductive signal is consequential; calling it natural does not establish safety. Community
Product uncertainty is more than a dose question. FDA's 2024 assessment identified limited chronic safety information and possible immune reactions associated with peptide impurities or aggregation. A labeled research product does not guarantee identity, sterility or fill accuracy; short experimental tolerability cannot establish long-term safety. Official context Community

Research behind the circulating claims

The four-minute clock comes from IV research. FDA summarizes a 3.8-minute plasma half-life in healthy men after IV infusion. SC absorption was not established as equivalent. This is clearance of peptide from blood, not duration of desire or downstream hormone effects. Official context
A larger IV dose did not produce a larger LH response. George et al. found maximal LH stimulation near 1 mcg/kg IV and a smaller response at 3 mcg/kg. Their infusions increased hormones, but those controlled exposures do not validate flat SC amounts, a permanent restart or PCT outcomes. Official context
The desensitization analogy involves Kisspeptin-54. Twice-daily versus twice-weekly research in women with hypothalamic amenorrhea found different loss of hormone responsiveness. The peptide form, population and endpoints differ from these Kisspeptin-10 libido diaries; it cannot establish their ideal cycle. Official context
The sexual-desire trial is supporting context. The male low-desire trial used 1 nmol/kg/hour Kisspeptin-54 IV for 75 minutes and found changes in sexual processing and arousal. It did not test home SC Kisspeptin-10, nasal schedules, PSSD or long-term fertility restoration. Official context

What the community accounts add

No benefit after two months also appears. One r/PSSD poster initially claimed at least 200 mcg daily with no change, then admitted taking half the amount they thought. They had not checked hormones during use. The nonresponse remains useful; the stated exposure is uncertain. Reddit r/PSSD
Libido and testicular size can diverge. The ExcelMale TRT user described improved comfort and libido but no restored size. They acknowledged other hormones could explain libido. That is a narrower outcome than an hCG-replacement claim. Personal report
Stacks make dramatic laboratory changes hard to interpret. Original talk pairs SC Kisspeptin-10 100 mcg two or three times weekly with oral enclomiphene 12.5 mg daily over 8–12 weeks. hCG, gonadorelin, PT-141, oxytocin and GH-axis peptides also appear. These are discussion examples, not checked combinations or a standardized blend. Community
People track more than total testosterone. Original lab talk includes LH, FSH, total/free testosterone and estradiol, sometimes prolactin and SHBG; baseline, three-to-four-week and eight-week comparisons recur. A 30–45-minute post-dose LH draw targets a different question. Feelings alone cannot identify hormone changes or their cause. Community